Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality tested as needle pain relief for dialysis patients

NCT ID NCT07334522

Symptom relief Sponsor: Karbala University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests whether wearing virtual reality (VR) glasses during needle insertion can reduce pain and anxiety in hemodialysis patients. 150 adults with end-stage kidney disease will either receive standard care or watch a calming 360-degree underwater video through VR goggles. Their pain and anxiety levels will be measured right after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality (VR) glasses showing a 360-degree underwater video with calming music
What this could lead to
If it works, this could offer a simple, drug-free way to make needle insertions less painful and stressful for dialysis patients.
What could go wrong
This is a small, early-stage trial. The effect may be small or not work for everyone. VR might cause motion sickness or discomfort in some people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

142 people

The number who actually took part.

Started

Jan 2026

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients with End-Stage Renal Disease (ESRD) on hemodialysis. * Patients using a functioning arteriovenous fistula (AVF). * Conscious, oriented, and able to communicate. * Normal or corrected vision and hearing suitable for VR use. * Patients capable of giving written informed consent. Exclusion Criteria: * History of motion sickness, seizures, or epilepsy. * Use of Central Venous Catheter (CVC) or Arteriovenous Graft (AVG). * Use of analgesics or sedatives within 4 hours before the procedure. * Facial wounds or eye infections preventing VR use. * Hemodynamic instability or cognitive impairment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia anxiety anxiety disorder congenital arteriovenous fistula end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Arteriovenous fistula Hemodialysis Needle insertion and injection pain Pain management Virtual reality

Contacts and locations

Locations

  • Imam Al-Hassan Al-Mujtaba Teaching Hospital

    Karbala, Iraq

  • Imam Al-Hussain Medical City

    Karbala, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.